These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 14528071

  • 1. Algorithm for the diagnosis of HER-2/neu status in breast-infiltrating carcinomas.
    Falo C, Moreno A, Lloveras B, Figueras A, Varela M, Escobedo A.
    Am J Clin Oncol; 2003 Oct; 26(5):465-70. PubMed ID: 14528071
    [Abstract] [Full Text] [Related]

  • 2. HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach.
    Ridolfi RL, Jamehdor MR, Arber JM.
    Mod Pathol; 2000 Aug; 13(8):866-73. PubMed ID: 10955453
    [Abstract] [Full Text] [Related]

  • 3. Comparison of immunohistochemical and fluorescence in situ hybridization assessment for HER-2/neu status in Taiwanese breast cancer patients.
    Kuo SJ, Wang BB, Chang CS, Chen TH, Yeh KT, Lee DJ, Yin PL, Chen M.
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):146-51. PubMed ID: 17638622
    [Abstract] [Full Text] [Related]

  • 4. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma.
    Couturier J, Vincent-Salomon A, Nicolas A, Beuzeboc P, Mouret E, Zafrani B, Sastre-Garau X.
    Mod Pathol; 2000 Nov; 13(11):1238-43. PubMed ID: 11106082
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine kinase activation in breast carcinoma with correlation to HER-2/neu gene amplification and receptor overexpression.
    Bhargava R, Naeem R, Marconi S, Luszcz J, Garb J, Gasparini R, Otis CN.
    Hum Pathol; 2001 Dec; 32(12):1344-50. PubMed ID: 11774167
    [Abstract] [Full Text] [Related]

  • 6. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE, Wallis T, Tabasczka P, Visscher DW.
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [Abstract] [Full Text] [Related]

  • 7. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma.
    Hoang MP, Sahin AA, Ordòñez NG, Sneige N.
    Am J Clin Pathol; 2000 Jun; 113(6):852-9. PubMed ID: 10874886
    [Abstract] [Full Text] [Related]

  • 8. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
    Prati R, Apple SK, He J, Gornbein JA, Chang HR.
    Breast J; 2005 Jun; 11(6):433-9. PubMed ID: 16297088
    [Abstract] [Full Text] [Related]

  • 9. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 10. Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.
    López-Guerrero JA, Navarro S, Noguera R, Almenar S, Pellin A, Vázquez C, Llombart-Bosch A.
    Arkh Patol; 2003 Dec; 65(1):50-5. PubMed ID: 12669615
    [Abstract] [Full Text] [Related]

  • 11. Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens.
    Lin F, Shen T, Prichard JW.
    Diagn Cytopathol; 2005 Dec; 33(6):376-80. PubMed ID: 16299744
    [Abstract] [Full Text] [Related]

  • 12. Intratumoral heterogeneity of her-2/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray.
    Shin SJ, Hyjek E, Early E, Knowles DM.
    Int J Surg Pathol; 2006 Oct; 14(4):279-84. PubMed ID: 17041191
    [Abstract] [Full Text] [Related]

  • 13. HER-2/neu in breast cancer: interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization.
    Thomson TA, Hayes MM, Spinelli JJ, Hilland E, Sawrenko C, Phillips D, Dupuis B, Parker RL.
    Mod Pathol; 2001 Nov; 14(11):1079-86. PubMed ID: 11706067
    [Abstract] [Full Text] [Related]

  • 14. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Nov; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 15. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 16. Defining a test for HER-2/neu evaluation in breast cancer in the diagnostic setting.
    Hanna WM, Kahn HJ, Pienkowska M, Blondal J, Seth A, Marks A.
    Mod Pathol; 2001 Jul; 14(7):677-85. PubMed ID: 11455000
    [Abstract] [Full Text] [Related]

  • 17. Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message.
    Tubbs RR, Pettay JD, Roche PC, Stoler MH, Jenkins RB, Grogan TM.
    J Clin Oncol; 2001 May 15; 19(10):2714-21. PubMed ID: 11352964
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
    Persons DL, Borelli KA, Hsu PH.
    Mod Pathol; 1997 Jul 15; 10(7):720-7. PubMed ID: 9237184
    [Abstract] [Full Text] [Related]

  • 19. HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases.
    Sáez A, Andreu FJ, Seguí MA, Baré ML, Fernández S, Dinarés C, Rey M.
    Breast; 2006 Aug 15; 15(4):519-27. PubMed ID: 16290155
    [Abstract] [Full Text] [Related]

  • 20. [Detection of HER-2/neu in breast carcinoma].
    Skálová A, Vanĕcek T, Losan F, Papoutsidesová, Fínek J.
    Cas Lek Cesk; 2003 Feb 15; 142(2):93-8. PubMed ID: 12698536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.